The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study

被引：0

作者：

Akito Nozaki

Masanori Atsukawa

Chisa Kondo

Hidenori Toyoda

Makoto Chuma

Makoto Nakamuta

Haruki Uojima

Koichi Takaguchi

Hiroki Ikeda

Tsunamasa Watanabe

Shintaro Ogawa

Norio Itokawa

Taeang Arai

Atsushi Hiraoka

Toru Asano

Shinichi Fujioka

Tadashi Ikegami

Toshihide Shima

Chikara Ogawa

Takehiro Akahane

Noritomo Shimada

Shinya Fukunishi

Hiroshi Abe

Akihito Tsubota

Takuya Genda

Hironao Okubo

Shigeru Mikami

Asahiro Morishita

Akio Moriya

Joji Tani

Yoshihiko Tachi

Naoki Hotta

Toru Ishikawa

Takeshi Okanoue

Yasuhito Tanaka

Takashi Kumada

Katsuhiko Iwakiri

Shin Maeda

机构：

[1] Yokohama City University Medical Center,Gastroenterological Center

[2] Nippon Medical School,Department of Internal Medicine, Division of Gastroenterology and Hepatology

[3] Ogaki Municipal Hospital,Department of Gastroenterology

[4] National Hospital Organization Kyushu Medical Center,Department of Gastroenterology, Internal Medicine

[5] Kitasato University School of Medicine,Department of Hepatology

[6] Kagawa Prefectural Central Hospital,Department of Internal Medicine

[7] St. Marianna University School of Medicine,Department of Virology and Liver Unit

[8] Nagoya City University,Division of Gastroenterology, Department of Internal Medicine

[9] Graduate School of Medical Sciences,Division of Gastroenterology, Department of Internal Medicine

[10] Nippon Medical School Chiba Hokusoh Hospital,Gastroenterology Center

[11] Nippon Medical School Musashikosugi Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[12] Ehime Prefectural Central Hospital,Department of Gastroenterology

[13] Tokyo Metropolitan Bokutoh Hospital,Department of Gastroenterology and Hepatology

[14] Okayama Saiseikai General Hospital,Department of Gastroenterology and Hepatology

[15] Tokyo Medical University Ibaraki Medical Center,Department of Gastroenterology

[16] Saiseikai Suita Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[17] Takamatsu Red Cross Hospital,Second Department of Internal Medicine

[18] Japanese Red Cross Ishinomaki Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[19] Otakanomori Hospital,Core Research Facilities for Basic Science

[20] Osaka Medical College,Department of Gastroenterology

[21] Shinmatsudo Central General Hospital,Department of Gastroenterology

[22] The Jikei University School of Medicine,Division of Gastroenterology, Department of Internal Medicine

[23] Juntendo Shizuoka University Hospital,Department of Gastroenterology

[24] Juntendo Nerima University Hospital,Department of Gastroenterology

[25] Kikkoman General Hospital,Department of Internal Medicine

[26] Kagawa University Graduate School of Medicine,Division of Hepatology, Department of Internal Medicine

[27] Mitoyo General Hospital,Department of Hepatology

[28] Yashima General Hospital,Department of Gastroenterology

[29] Bantane Hospital,undefined

[30] Fujita Health University School of Medicine,undefined

[31] Masuko Memorial Hospital,undefined

[32] Saiseikai Niigata Daini Hospital,undefined

[33] Yokohama City University Graduate School of Medicine,undefined

来源：

Hepatology International | 2020年 / 14卷

关键词：

Glecaprevir; Pibrentasvir; Chronic hepatitis C; Refractory factors; Multicenter study;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：225 / 238

页数：13

共 50 条

[21] Real-life Data of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: A Single-center Study
Cabalak, Mehmet
Bal, Tayibe
Ocak, Sabahattin
Bal, Isa Ahmet
Onlen, Yusuf
HEPATITIS MONTHLY, 2023, 23 (01)
[22] A real-world clinical application of the combination therapy with glecaprevir/pibrentasvir to special population in chronic hepatitis C patients
Sato, Ken
Yamazaki, Yuichi
Kobayashi, Takeshi
Tojima, Hiroaki
Horiguchi, Norio
Kakizaki, Satoru
Uraoka, Toshio
Ohnishi, Hiroshi
Okamoto, Hiroaki
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 444 - 444
[23] Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients
Margusino-Framinan, Luis
Cid-Silva, Purificacion
Rotea-Salvo, Sandra
Mena-de-Cea, Alvaro
Suarez-Lopez, Francisco
Vazquez-Rodriguez, Pilar
Delgado-Blanco, Manuel
Sanclaudio-Luhia, Ana Isabel
Martin-Herranz, Isabel
Castro-Iglesias, Angeles
EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2020, 27 (E1) : E41 - E47
[24] Real-world Effectiveness of Glecaprevir/Pibrentasvir (GLE/PIB) for Chronic Hepatitis C Infection: Evidence From a German Single-center Cohort Study
Beisel, Claudia
Herrmann, Marissa
Piecha, Felix
Lampalzer, Sibylle
Buescher, Gustav
Pischke, Sven
Wiesch, Julian Schulze zur
HEPATITIS MONTHLY, 2021, 21 (01)
[25] Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older
Foster, Graham R.
Asselah, Tarik
Kopecky-Bromberg, Sarah
Lei, Yang
Asatryan, Armen
Trinh, Roger
Zadeikis, Neddie
Mensa, Federico J.
PLOS ONE, 2019, 14 (01):
[26] Efficacy and safety of glecaprevir and pibrentasvir in Saudi patients with chronic hepatitis C virus infection at a major tertiary hospital
Ruwayni, Ali A.
Alobary, Eman E.
Alyahya, Khalid M.
SAUDI MEDICAL JOURNAL, 2024, 45 (01) : 34 - 39
[27] Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R)
Cornberg, Markus
Stoehr, Albrecht
Naumann, Uwe
Teuber, Gerlinde
Klinker, Hartwig
Lutz, Thomas
Moller, Hjoerdis
Hidde, Dennis
Lohmann, Kristina
Simon, Karl-Georg
VIRUSES-BASEL, 2022, 14 (07):
[28] Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
Liu, Chen-Hua
Yang, Sheng-Shun
Peng, Cheng-Yuan
Lin, Woan-Tyy
Liu, Chun-Jen
Su, Tung-Hung
Tseng, Tai-Chung
Chen, Pei-Jer
Chen, Ding-Shinn
Kao, Jia-Horng
JOURNAL OF VIRAL HEPATITIS, 2020, 27 (06) : 568 - 575
[29] Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis
Back, David
Belperio, Pamela
Bondin, Mark
Negro, Francesco
Talal, Andrew H.
Park, Caroline
Zhang, ZhenZhen
Pinsky, Brett
Crown, Eric
Mensa, Federico J.
Marra, Fiona
JOURNAL OF VIRAL HEPATITIS, 2019, 26 (08) : 951 - 960
[30] Real-world Effectiveness and Safety of Direct-acting Antiviral Agents in Patients with Chronic Hepatitis C Genotype 2 Infection: Korean Multicenter Study
Kang, Yeo Wool
Baek, Yang Hyun
Lee, Sung Wook
Park, Sung-Jae
Yoon, Jun Sik
Yoon, Ki Tae
Hong, Youngmi
Heo, Nae-Yun
Seo, Kwang Il
Lee, Sang Soo
Cho, Hyun Chin
Shin, Jung Woo
JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (21)

← 1 2 3 4 5 →